Nutraceuticals and OTC Products: Where Do They Fit in Indian Pharma Trade?
The boundary between pharmaceuticals, nutraceuticals, and over-the-counter (OTC) consumer health products is not always clear — and the classification differences have real implications for import documentation, licensing, and regulatory compliance. For international buyers sourcing health products from India, understanding how India defines these categories is important groundwork.
---
How India Classifies Health Products
Indian regulation draws lines between several product categories, each with different regulatory frameworks:
1. Drugs / Pharmaceuticals
Regulated under the Drugs & Cosmetics Act, 1940 (D&C Act). Includes: - Prescription medicines (Schedule H, H1, X) - Non-prescription / Over-the-Counter (OTC) medicines (unscheduled or specifically designated) - Homeopathic medicines (regulated under D&C Act but with separate schedule) - Medical devices (regulated under the D&C Act and Medical Devices Rules, 2017)Manufacturers require a drug manufacturing licence; traders require a drug wholesale/retail licence.
2. Food Products Including Nutraceuticals and Dietary Supplements
Regulated under the Food Safety and Standards Act, 2006 (FSSA) and administered by the Food Safety and Standards Authority of India (FSSAI). Includes: - Nutraceuticals (e.g., omega-3, probiotics, vitamins above certain thresholds) - Dietary supplements - Functional foods - Foods for special dietary usesManufacturers and importers of food products require FSSAI registration or licence, not a drug licence.
3. Cosmetics
Regulated under the D&C Act (Cosmetics section). Includes topical products with no therapeutic claims — skin care, hair care, etc.---
The OTC Question in India
India does not yet have a comprehensively defined "OTC" category in the way some Western markets do. Products that are not listed under Schedule H, H1, or X of the Drugs Rules are effectively non-prescription products — but there is no single "OTC approved" list for India equivalent to, say, the US FDA's OTC drug monograph system.
Products not covered by any schedule restriction can be sold without a prescription by a licensed drug retailer. However, their marketing, labelling, and distribution still fall under the D&C Act if they carry therapeutic claims.
Key regulatory risk for buyers: A product that is labelled as a food/supplement in your importing country may be classified as a drug in India, or vice versa. This matters for import classification, customs duties, and regulatory documentation.---
The Dual Regulation Risk
A product that makes therapeutic claims (e.g., "supports joint health," "boosts immunity") may be considered a drug if the claim implies treatment or prevention of a disease. The same product without a therapeutic claim may be a food supplement.
This boundary is actively contested in India — FSSAI and CDSCO have differing perspectives on products like: - High-dose vitamins and minerals - Herbal products with health claims - Protein supplements with added functional ingredients
For import buyers, the practical consequence is: the classification of your product in India may differ from its classification in your country. If importing a product that sits on this boundary, confirm its classification (drug or food) under Indian regulation before procurement, as this determines the applicable manufacturing licences and export documentation.
---
Implications for International Buyers
If you are importing a product classified as a drug in India: - Manufacturer must hold a drug manufacturing licence - Exporter must hold a drug wholesale licence and IEC - Export documentation follows pharmaceutical norms (CoA, FSC from State FDA or CDSCO, Form 40/41 if required) If you are importing a product classified as a food/nutraceutical in India: - Manufacturer must hold an FSSAI licence - Export documentation follows food export norms (Health Certificate from FSSAI or EIC, Certificate of Origin, etc.) - Import classification in your country may still place it in a pharmaceutical/controlled category — check your national rules When in doubt: Engage a regulatory consultant in both India and your importing country before committing to a procurement of borderline products. Misclassification creates customs clearance problems, potential product seizure, and regulatory exposure.---
Bharat Medex's core range covers pharmaceutical products (drugs) — ethical medicines, generics, and surgical items. For nutraceutical and food-classified products, we recommend confirming product classification and documentation requirements directly with a regulatory specialist.
Contact us to discuss your specific product requirements.
0 comments